--- title: "Top 10 港股涨幅(10月22日)" description: "轩竹生物-B(02575) 涨 31.87%,成交额 2.8 亿港元,年内累计涨 417.2%。 中铝国际 (02068) 涨 30.52%,成交额 5.4 亿港元,年内累计涨 77.6%。 中渝置地 (01224) 涨 25%,成交额 3159.8 万港元,年内累计涨 27.1%。" type: "news" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/262188959.md" published_at: "2025-10-22T08:30:41.000Z" --- # Top 10 港股涨幅(10月22日) > 轩竹生物-B(02575) 涨 31.87%,成交额 2.8 亿港元,年内累计涨 417.2%。 中铝国际 (02068) 涨 30.52%,成交额 5.4 亿港元,年内累计涨 77.6%。 中渝置地 (01224) 涨 25%,成交额 3159.8 万港元,年内累计涨 27.1%。 恒生指数跌 0.94%,年内累计涨 28.5%;恒生科技指数跌 1.41%,年内累计涨 32.6%。 轩竹生物-B(02575) 涨 31.87%,成交额 2.8 亿港元,年内累计涨 417.2%。 中铝国际 (02068) 涨 30.52%,成交额 5.4 亿港元,年内累计涨 77.6%。 中渝置地 (01224) 涨 25%,成交额 3159.8 万港元,年内累计涨 27.1%。 ### Related Stocks - [02575.HK - 轩竹生物-B](https://longbridge.com/zh-CN/quote/02575.HK.md) - [02068.HK - 中铝国际](https://longbridge.com/zh-CN/quote/02068.HK.md) - [01224.HK - 中渝置地](https://longbridge.com/zh-CN/quote/01224.HK.md) - [02617.HK - 药捷安康-B](https://longbridge.com/zh-CN/quote/02617.HK.md) - [01115.HK - 5100藏冰川](https://longbridge.com/zh-CN/quote/01115.HK.md) - [01126.HK - 德林国际](https://longbridge.com/zh-CN/quote/01126.HK.md) - [00259.HK - 亿都(国际控股)](https://longbridge.com/zh-CN/quote/00259.HK.md) - [02005.HK - 石四药集团](https://longbridge.com/zh-CN/quote/02005.HK.md) - [00931.HK - 中国港能](https://longbridge.com/zh-CN/quote/00931.HK.md) - [01033.HK - 中石化油服](https://longbridge.com/zh-CN/quote/01033.HK.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | SSY Group Gets Bulk Drug Approvals for Two Products in China | SSY Group Gets Bulk Drug Approvals for Two Products in China | [Link](https://longbridge.com/zh-CN/news/275313672.md) | | SSY Group Secures NMPA Approval for Phloroglucinol Trimethyl Ether and Dobutamine Hydrochloride | SSY Group Ltd. has received approval from the National Medical Products Administration of China (NMPA) for the registrat | [Link](https://longbridge.com/zh-CN/news/275301786.md) | | Xuanzhu Biopharmaceutical Details Board and Committee Composition | Xuanzhu Biopharmaceutical Co., Ltd. has announced the composition of its board of directors, led by Chairperson Ms. Xu Y | [Link](https://longbridge.com/zh-CN/news/271497565.md) | | SSY Group Receives Approval for 2ml Composite Potassium Hydrogen Phosphate Injection in China | SSY Group Ltd. has received approval from China's National Medical Products Administration for its 2ml Composite Potassi | [Link](https://longbridge.com/zh-CN/news/273678089.md) | | SSY Group logs 9m net income HKD 399 mln | SSY Group logs 9m net income HKD 399 mln | [Link](https://longbridge.com/zh-CN/news/263041339.md) | --- > **免责声明**:本文内容仅供参考,不构成任何投资建议。